CN111358895A - 治疗糖尿病、心脑血管疾病的中药组合药物及其制备方法 - Google Patents
治疗糖尿病、心脑血管疾病的中药组合药物及其制备方法 Download PDFInfo
- Publication number
- CN111358895A CN111358895A CN202010412871.XA CN202010412871A CN111358895A CN 111358895 A CN111358895 A CN 111358895A CN 202010412871 A CN202010412871 A CN 202010412871A CN 111358895 A CN111358895 A CN 111358895A
- Authority
- CN
- China
- Prior art keywords
- parts
- cardiovascular
- radix
- treating diabetes
- cerebrovascular diseases
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010012601 diabetes mellitus Diseases 0.000 title claims abstract description 45
- 208000024172 Cardiovascular disease Diseases 0.000 title claims abstract description 39
- 208000026106 cerebrovascular disease Diseases 0.000 title claims abstract description 39
- 230000002526 effect on cardiovascular system Effects 0.000 title claims abstract description 39
- 239000000203 mixture Substances 0.000 title claims abstract description 37
- 238000002360 preparation method Methods 0.000 title claims abstract description 20
- 239000003814 drug Substances 0.000 claims abstract description 42
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 20
- 244000197580 Poria cocos Species 0.000 claims abstract description 18
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 18
- 240000006079 Schisandra chinensis Species 0.000 claims abstract description 17
- 239000000463 material Substances 0.000 claims abstract description 17
- 244000124209 Crocus sativus Species 0.000 claims abstract description 16
- 235000015655 Crocus sativus Nutrition 0.000 claims abstract description 16
- 235000002722 Dioscorea batatas Nutrition 0.000 claims abstract description 16
- 235000006536 Dioscorea esculenta Nutrition 0.000 claims abstract description 16
- 240000001811 Dioscorea oppositifolia Species 0.000 claims abstract description 16
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 claims abstract description 16
- 241000304195 Salvia miltiorrhiza Species 0.000 claims abstract description 16
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 claims abstract description 16
- 235000013974 saffron Nutrition 0.000 claims abstract description 16
- 239000004248 saffron Substances 0.000 claims abstract description 16
- 241000208688 Eucommia Species 0.000 claims abstract description 15
- 239000000706 filtrate Substances 0.000 claims abstract description 14
- 241000045403 Astragalus propinquus Species 0.000 claims abstract description 12
- 241000037740 Coptis chinensis Species 0.000 claims abstract description 12
- 235000006533 astragalus Nutrition 0.000 claims abstract description 12
- 210000003038 endothelium Anatomy 0.000 claims abstract description 12
- 238000002156 mixing Methods 0.000 claims abstract description 10
- 241001633574 Adenophora stricta Species 0.000 claims abstract description 8
- 240000004638 Dendrobium nobile Species 0.000 claims abstract description 8
- 241000287828 Gallus gallus Species 0.000 claims abstract description 8
- 239000012528 membrane Substances 0.000 claims abstract description 8
- 241000209020 Cornus Species 0.000 claims abstract description 7
- 238000001914 filtration Methods 0.000 claims abstract description 7
- 239000009636 Huang Qi Substances 0.000 claims abstract description 4
- 235000017784 Mespilus germanica Nutrition 0.000 claims abstract description 4
- 244000182216 Mimusops elengi Species 0.000 claims abstract description 4
- 235000000560 Mimusops elengi Nutrition 0.000 claims abstract description 4
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims abstract description 4
- 235000007837 Vangueria infausta Nutrition 0.000 claims abstract description 4
- 210000000582 semen Anatomy 0.000 claims abstract description 4
- 238000005303 weighing Methods 0.000 claims abstract description 4
- 241000213006 Angelica dahurica Species 0.000 claims abstract 3
- 244000126002 Ziziphus vulgaris Species 0.000 claims abstract 3
- 244000241838 Lycium barbarum Species 0.000 claims description 12
- 235000015459 Lycium barbarum Nutrition 0.000 claims description 12
- 235000015468 Lycium chinense Nutrition 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 9
- 230000008569 process Effects 0.000 claims description 6
- 241001412627 Adenophora liliifolia Species 0.000 claims description 4
- 235000002991 Coptis groenlandica Nutrition 0.000 claims description 4
- 241001523681 Dendrobium Species 0.000 claims description 4
- 239000002671 adjuvant Substances 0.000 claims description 4
- 229940107666 astragalus root Drugs 0.000 claims description 4
- 241000405414 Rehmannia Species 0.000 claims description 3
- 239000002775 capsule Substances 0.000 claims description 3
- 239000008187 granular material Substances 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 3
- 239000002674 ointment Substances 0.000 claims description 3
- 239000006187 pill Substances 0.000 claims description 3
- 239000000843 powder Substances 0.000 claims description 3
- 239000003826 tablet Substances 0.000 claims description 3
- 244000247747 Coptis groenlandica Species 0.000 claims 1
- 230000000694 effects Effects 0.000 description 23
- 239000008280 blood Substances 0.000 description 20
- 210000004369 blood Anatomy 0.000 description 20
- 210000002216 heart Anatomy 0.000 description 15
- 230000001737 promoting effect Effects 0.000 description 14
- 241000382455 Angelica sinensis Species 0.000 description 13
- 241001247821 Ziziphus Species 0.000 description 13
- 230000036772 blood pressure Effects 0.000 description 11
- 210000003734 kidney Anatomy 0.000 description 11
- 210000000952 spleen Anatomy 0.000 description 10
- 241000759833 Cornus officinalis Species 0.000 description 9
- 208000002193 Pain Diseases 0.000 description 7
- 230000001976 improved effect Effects 0.000 description 7
- 210000004185 liver Anatomy 0.000 description 7
- 210000002784 stomach Anatomy 0.000 description 7
- 235000008422 Schisandra chinensis Nutrition 0.000 description 6
- 235000009508 confectionery Nutrition 0.000 description 6
- 206010003210 Arteriosclerosis Diseases 0.000 description 5
- 208000011775 arteriosclerosis disease Diseases 0.000 description 5
- 230000007812 deficiency Effects 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 208000007536 Thrombosis Diseases 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- 210000004556 brain Anatomy 0.000 description 4
- 210000004072 lung Anatomy 0.000 description 4
- 210000000496 pancreas Anatomy 0.000 description 4
- 235000019640 taste Nutrition 0.000 description 4
- 241000218202 Coptis Species 0.000 description 3
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 3
- 206010033557 Palpitations Diseases 0.000 description 3
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- 206010022437 insomnia Diseases 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000008108 microcrystalline cellulose Substances 0.000 description 3
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 3
- 229940016286 microcrystalline cellulose Drugs 0.000 description 3
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 3
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 3
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- 235000019605 sweet taste sensations Nutrition 0.000 description 3
- 210000002700 urine Anatomy 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 206010003549 asthenia Diseases 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 230000001914 calming effect Effects 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 239000000945 filler Substances 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 244000237330 gutta percha tree Species 0.000 description 2
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 2
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 2
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 2
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 2
- 239000000314 lubricant Substances 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 239000000375 suspending agent Substances 0.000 description 2
- 230000035900 sweating Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 230000002936 tranquilizing effect Effects 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- XUFXOAAUWZOOIT-SXARVLRPSA-N (2R,3R,4R,5S,6R)-5-[[(2R,3R,4R,5S,6R)-5-[[(2R,3R,4S,5S,6R)-3,4-dihydroxy-6-methyl-5-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)-1-cyclohex-2-enyl]amino]-2-oxanyl]oxy]-3,4-dihydroxy-6-(hydroxymethyl)-2-oxanyl]oxy]-6-(hydroxymethyl)oxane-2,3,4-triol Chemical compound O([C@H]1O[C@H](CO)[C@H]([C@@H]([C@H]1O)O)O[C@H]1O[C@@H]([C@H]([C@H](O)[C@H]1O)N[C@@H]1[C@@H]([C@@H](O)[C@H](O)C(CO)=C1)O)C)[C@@H]1[C@@H](CO)O[C@@H](O)[C@H](O)[C@H]1O XUFXOAAUWZOOIT-SXARVLRPSA-N 0.000 description 1
- LQIAZOCLNBBZQK-UHFFFAOYSA-N 1-(1,2-Diphosphanylethyl)pyrrolidin-2-one Chemical compound PCC(P)N1CCCC1=O LQIAZOCLNBBZQK-UHFFFAOYSA-N 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 241000173529 Aconitum napellus Species 0.000 description 1
- 244000205574 Acorus calamus Species 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 208000033386 Buerger disease Diseases 0.000 description 1
- 235000011996 Calamus deerratus Nutrition 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 206010008132 Cerebral thrombosis Diseases 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 208000001380 Diabetic Ketoacidosis Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- 208000036119 Frailty Diseases 0.000 description 1
- 241000096284 Gynochthodes officinalis Species 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 208000031361 Hiccup Diseases 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- 208000013016 Hypoglycemia Diseases 0.000 description 1
- 208000006083 Hypokinesia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 201000001429 Intracranial Thrombosis Diseases 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 229920000881 Modified starch Polymers 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 229930195210 Ophiopogon Natural products 0.000 description 1
- 244000248557 Ophiopogon japonicus Species 0.000 description 1
- 235000001188 Peltandra virginica Nutrition 0.000 description 1
- 241001080798 Polygala tenuifolia Species 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 240000007164 Salvia officinalis Species 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 206010041497 Spermatorrhoea Diseases 0.000 description 1
- 206010043540 Thromboangiitis obliterans Diseases 0.000 description 1
- 206010046555 Urinary retention Diseases 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 229960002632 acarbose Drugs 0.000 description 1
- XUFXOAAUWZOOIT-UHFFFAOYSA-N acarviostatin I01 Natural products OC1C(O)C(NC2C(C(O)C(O)C(CO)=C2)O)C(C)OC1OC(C(C1O)O)C(CO)OC1OC1C(CO)OC(O)C(O)C1O XUFXOAAUWZOOIT-UHFFFAOYSA-N 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 229940023019 aconite Drugs 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000007969 cellular immunity Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 230000000225 effect on diabetes Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- 229940044949 eucalyptus oil Drugs 0.000 description 1
- 239000010642 eucalyptus oil Substances 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 230000006651 lactation Effects 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- XZWYZXLIPXDOLR-UHFFFAOYSA-N metformin Chemical compound CN(C)C(=N)NC(N)=N XZWYZXLIPXDOLR-UHFFFAOYSA-N 0.000 description 1
- 229960003105 metformin Drugs 0.000 description 1
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 1
- 229960001300 metoprolol tartrate Drugs 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 235000005412 red sage Nutrition 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 235000012222 talc Nutrition 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- WUBVEMGCQRSBBT-UHFFFAOYSA-N tert-butyl 4-(trifluoromethylsulfonyloxy)-3,6-dihydro-2h-pyridine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCC(OS(=O)(=O)C(F)(F)F)=CC1 WUBVEMGCQRSBBT-UHFFFAOYSA-N 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 210000004916 vomit Anatomy 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
- A61K36/342—Adenophora
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/40—Cornaceae (Dogwood family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/46—Eucommiaceae (Eucommia family), e.g. hardy rubber tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/718—Coptis (goldthread)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
- A61K36/725—Ziziphus, e.g. jujube
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/79—Schisandraceae (Schisandra family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/83—Thymelaeaceae (Mezereum family), e.g. leatherwood or false ohelo
- A61K36/835—Aquilaria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
- A61K36/8984—Dendrobium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种治疗糖尿病、心脑血管疾病的中药组合药物及其制备方法。治疗糖尿病、心脑血管疾病的中药组合药物,其特征在于,按质量份数计,包括:藏红花8‑15份、山药10‑20份、生地10‑20份、沙参10‑20份、枣仁15‑25份、漏芦10‑20份、杜仲10‑22份、黄连5‑15份、鸡内金10‑20份、五味子15‑25份、当归10‑20份、茯苓10‑20份、黄芪10‑30份、山萸肉10‑30份、沉香5‑15份、石斛10‑20份、丹参10‑22份、杞子15‑25份。治疗糖尿病、心脑血管疾病的中药组合药物制备方法,包括:分别称取藏红花、山药、生地、沙参、枣仁、漏芦、杜仲、黄连、鸡内金、五味子、当归、茯苓、黄芪、山萸肉、沉香、石斛、丹参、杞子,将所有药材混合,加入水,文火熬制1.5‑2h,过滤,分出药渣和滤液,将滤液提纯,制成浓缩液。
Description
技术领域
本发明涉及中药技术领域,特别是涉及一种治疗糖尿病、心脑血管疾病的中药组合药物及其制备方法。
背景技术
糖尿病、心脑血管疾病是目前死亡率非常高的两大系统疾病,患者的病程长、生活质量差、并发症、后遗症多。目前,还没有有效的治疗方法和治疗药物,现有技术的药物主要是针对糖尿病、心脑血管疾病病的防治、控制、有效解决、病情加重、并发症发生、防止后遗症发生。
发明内容
基于此,本发明的目的在于,提供一种治疗糖尿病、心脑血管疾病的中药组合药物及其制备方法。
本发明的治疗糖尿病、心脑血管疾病的中药组合药物,按质量份数计,包括:藏红花8-15份、山药10-20份、生地10-20份、沙参10-20份、枣仁15-25份、漏芦10-20份、杜仲10-22份、黄连5-15份、鸡内金10-20份、五味子15-25份、当归10-20份、茯苓10-20份、黄芪10-30份、山萸肉10-30份、沉香5-15份、石斛10-20份、丹参10-22份、杞子15-25份。
本发明治疗糖尿病、心脑血管疾病的中药组合药物通过添加藏红花、山药、生地、沙参、枣仁、漏芦、杜仲、黄连、鸡内金、五味子、当归、茯苓、黄芪、山萸肉、沉香、石斛、丹参和杞子等成分,可以有效提高患者的提免修复能力,安心、降压、护心脑、保修胰腺,既能温阳降糖,又能滋阴降压,且能减轻动脉硬化,避免血栓形成和动脉硬化性闭塞,对糖尿病和心血管疾病均有显著的治疗效果。
上述技术方案在一种实施方式中,按质量份数计,包括:藏红花10份、山药15份、生地15份、沙参15份、枣仁20份、漏芦15份、杜仲15份、黄连10份、鸡内金15份、五味子20份、当归15份、茯苓15份、黄芪20份、山萸肉20份、沉香10份、石斛15份、丹参15份、杞子20份。
本发明还进一步提供了一种治疗糖尿病、心脑血管疾病的中药组合药物制备方法,包括:分别称取藏红花、山药、生地、沙参、枣仁、漏芦、杜仲、黄连、鸡内金、五味子、当归、茯苓、黄芪、山萸肉、沉香、石斛、丹参、杞子,将所有药材混合,加入水,文火熬制1.5-2h,过滤,分出药渣和滤液,将滤液提纯,制成浓缩液。
本发明的治疗糖尿病、心脑血管疾病的中药组合药物制备方法的工艺简单,材料来源广泛,适于进行推广应用。
上述技术方案在一种实施方式中,所述将所有药材混合,加入水,包括:将所有药材混合,加入水,其中,所有药材的总质量与水的质量比为1:10。
上述技术方案在一种实施方式中,将药渣再次回收利用,加入水,其中,药渣的质量与水的质量比为1:8,文火熬制1.5-2h,过滤得到滤液,将滤液提纯,制成浓缩液。
上述技术方案在一种实施方式中,所述制备方法还包括:浓缩液加入常规辅料,按照常规工艺,制成临床上可接受的口服液、片剂、颗粒、胶囊、丸剂、散剂、膏剂。
本发明治疗糖尿病、心脑血管疾病的中药组合药物及其制备方法的效果:
(1)本发明的治疗糖尿病、心脑血管疾病的中药组合药物通过添加藏红花份、山药、生地、沙参、枣仁、漏芦、杜仲、黄连、鸡内金、五味子、当归、茯苓、黄芪、山萸肉、沉香、石斛、丹参和杞子等成分,可以有效提高患者的提免修复能力,安心、降压、护心脑、保修胰腺,既能温阳降糖,又能滋阴降压,且能减轻动脉硬化,避免血栓形成和动脉硬化性闭塞,对糖尿病和心血管疾病均有显著的治疗效果。
(2)本发明的治疗糖尿病、心脑血管疾病的中药组合药物制备方法的工艺简单,材料来源广泛,适于进行推广应用。
具体实施方式
以下示例性实施例中所描述的实施方式并不代表与本公开相一致的所有实施方式。相反,它们仅是与如所附权利要求书中所详述的、本公开的一些方面相一致的方法的例子。
在本公开使用的术语是仅仅出于描述特定实施例的目的,而非旨在限制本公开。在本公开和所附权利要求书中所使用的单数形式的“一种”、“所述”和“该”也旨在包括多数形式,除非上下文清楚地表示其他含义。还应当理解,本文中使用的术语“和/或”是指并包含一个或多个相关联的列出项目的任何或所有可能组合。
本发明的治疗糖尿病、心脑血管疾病的中药组合药物,按质量份数计,包括:藏红花8-15份、山药10-20份、生地10-20份、沙参10-20份、枣仁15-25份、漏芦10-20份、杜仲10-22份、黄连5-15份、鸡内金10-20份、五味子15-25份、当归10-20份、茯苓10-20份、黄芪10-30份、山萸肉10-30份、沉香5-15份、石斛10-20份、丹参10-22份、杞子15-25份。
本发明的治疗糖尿病、心脑血管疾病的中药组合药物通过添加藏红花份、山药、生地、沙参、枣仁、漏芦、杜仲、黄连、鸡内金、五味子、当归、茯苓、黄芪、山萸肉、沉香、石斛、丹参和杞子等成分,可以有效提高患者的提免修复能力,安心、降压、护心脑、保修胰腺,既能温阳降糖,又能滋阴降压,且能减轻动脉硬化,避免血栓形成和动脉硬化性闭塞,对糖尿病和心血管疾病均有显著的治疗效果。
本发明治疗糖尿病、心脑血管疾病的中药组合药物各成分的作用如下:
藏红花:味甘、性平、无毒,具有活血化瘀、通络、凉血解毒、消炎止痛等功效。
山药:具有健脾、补肺、固肾、益精之功效。
生地:具有清热解毒、养阴生津等功效,因为生地属于寒性食物,食用之后能够起到促进血液凝固、降低血糖、强心利尿、保护肝脏等作用。
沙参:味甘、微苦,性微寒,养阴清热、益胃生津、润肺化痰。
枣仁:味甘,性平;归心、脾、肝、胆经;具有养肝、宁心、安神、敛汗等功效,治虚烦不眠、惊悸怔忡、烦渴、虚汗等。
漏芦:苦,寒。清热解毒,消痈散结,通经下乳,舒筋通脉。现代医学研究有减轻动脉硬化及提高细胞免疫的功能。
杜仲:味辛,平,入肾经。《神农本草经》记载“腰脊痛、补中益精气、坚筋骨、强志、除阴下痒湿、小便余沥”。《本草纲目》记载:“杜仲,能入肝,补中益精气,坚筋骨,强志,治肾虚腰痛,久服,轻身耐老”,可见杜仲具有补肝肾,强筋骨的功效。
黄连:味苦,性寒;归心经;具有热燥湿,泻火解毒等功效。
鸡内金:味甘,性寒,有消食健胃,涩精止遗之功效,用于治疗食积胀满,呕吐返胃,消渴,遗精等症。用于糖尿病的防治,以补助脾胃,运化饮食为主。消磨瘀积,食化积消,高血糖自然可除。鸡内金因“能化瘀血,又不伤气分,尤适于气分虚甚者。
五味子:味甘、酸,性温,具有收敛固涩,益气生津,补肾宁心之功效,用于治疗久嗽虚喘,内热消渴,津伤口渴,短气脉虚,久泻不止,心悸失眠等症。
当归:性味甘、辛,温。归肝、心、脾经。具有补血调经,活血止痛,润肠通便的作用。
茯苓:甘、淡,平。归心、脾、肾经。利水渗湿、健脾、安神。主治水肿,小便不利,脾胃虚弱,食少纳呆,倦怠乏力,脾虚湿泻,心悸,失眠。有镇静和降低血糖作用。
黄芪:味甘,性微温,具有补气固表,利水退肿,托毒排脓,生肌等功效,现代药理研究有降糖作用。
山萸肉:补肝肾阴,巴戟天温壮肾阳,配以制附子之辛热,以温阳下元,引火归元,麦冬五味子滋养肺肾,金水相生,与昌蒲、远志、茯苓合用能开窍化痰,既能温阳降糖,又能滋阴降压。
沉香:味辛、苦,性微温。归脾、胃、肾经。具有行气止痛、温中止呕、纳气平喘的功效。主要用于治疗胸腹胀闷疼痛、胃寒呕吐呃逆、肾虚气逆喘急等。
石斛:石斛含有酯类成分,具有活血化瘀、扩张血管及抗血小板凝结,治疗血栓闭塞脉搏管炎,脑血栓形成,动脉硬化性闭塞等作用。
丹参:丹参的干燥根和根茎,具有活血祛瘀,痛经止痛,清心除烦,净血消痛的功效。此处丹参还降低血糖,防治糖尿病,并发症,滴草血脂,改变微循环的作用,经常服用可以预防和治疗糖尿病及糖尿病异改的酮症酸中毒和低血糖。
杞子:味甘,性平,滋肾,润肺,补肝,明目,用于肝肾阴亏,腰膝酸软,头晕,目眩,目昏多泪,虚劳咳嗽,消渴,遗精等症。
实施例一
本实施例的治疗糖尿病、心脑血管疾病的中药组合药物,按质量份数计,包括:藏红花10份、山药15份、生地15份、沙参15份、枣仁20份、漏芦15份、杜仲15份、黄连10份、鸡内金15份、五味子20份、当归15份、茯苓15份、黄芪20份、山萸肉20份、沉香10份、石斛15份、丹参15份、杞子20份。
实施例二
本实施例的治疗糖尿病、心脑血管疾病的中药组合药物,按质量份数计,包括:藏红花8份、山药20份、生地20份、沙参20份、枣仁15份、漏芦10份、杜仲22份、黄连15份、鸡内金10份、五味子25份、当归10份、茯苓20份、黄芪10份、山萸肉30份、沉香5份、石斛10份、丹参10份、杞子25份。
实施例三
本实施例的治疗糖尿病、心脑血管疾病的中药组合药物,按质量份数计,包括:藏红花15份、山药10份、生地10份、沙参10份、枣仁25份、漏芦20份、杜仲10份、黄连5份、鸡内金20份、五味子15份、当归20份、茯苓10份、黄芪30份、山萸肉10份、沉香15份、石斛20份、丹参22份、杞子15份。
实施例四
本实施例的治疗糖尿病、心脑血管疾病的中药组合药物,按质量份数计,包括:藏红花12份、山药18份、生地12份、沙参16份、枣仁22份、漏芦13份、杜仲20份、黄连8份、鸡内金17份、五味子21份、当归19份、茯苓14份、黄芪22份、山萸肉21份、沉香11份、石斛17份、丹参20份、杞子22份。
实施例五
本实施例的治疗糖尿病、心脑血管疾病的中药组合药物,按质量份数计,包括:藏红花9份、山药13份、生地17份、沙参13份、枣仁16份、漏芦17份、杜仲12份、黄连11份、鸡内金13份、五味子21份、当归13份、茯苓19份、黄芪17份、山萸肉15份、沉香9份、石斛11份、丹参18份、杞子16份。
本发明治疗糖尿病、心脑血管疾病的中药组合药物是根据“核磁中医平衡疗法”原理配伍治疗,在临床上治疗效果显著。
本发明的治疗糖尿病、心脑血管疾病的中药组合药物制备方法,可以用于制备上述任一实施例的治疗糖尿病、心脑血管疾病的中药组合药物,其包括:分别称取藏红花、山药、生地、沙参、枣仁、漏芦、杜仲、黄连、鸡内金、五味子、当归、茯苓、黄芪、山萸肉、沉香、石斛、丹参、杞子,将所有药材混合,加入水,文火熬制1.5-2h,过滤,分出药渣和滤液,将滤液提纯,制成浓缩液。
优选地,所述将所有药材混合,加入水,包括:将所有药材混合,加入水,其中,所有药材的总质量与水的质量比为1:10。
进一步优选地,将药渣再次回收利用,加入水,其中,药渣的质量与水的质量比为1:8,文火熬制1.5-2h,过滤得到滤液,将滤液提纯,制成浓缩液。
所述制备方法还包括:浓缩液加入常规辅料,按照常规工艺,制成临床上可接受的口服液、片剂、颗粒、胶囊、丸剂、散剂、膏剂。
优选地,所述常规辅料包括填充剂、崩解剂、润滑剂、助悬剂、粘合剂、防腐剂、基质等。
具体地,填充剂包括:淀粉、乳糖、甘露醇、甲壳素、微晶纤维素、蔗糖等。
崩解剂包括:淀粉、预胶化淀粉、微晶纤维素、交联聚乙烯吡咯烷酮等。
润滑剂包括:硬脂酸镁、十二烷基硫酸钠、滑石粉、二氧化硅等。
助悬剂包括:聚乙烯吡咯烷酮、微晶纤维素、蔗糖、琼脂、羟丙基甲基纤维素等。
粘合剂包括,淀粉浆、聚乙烯吡咯烷酮、羟丙基甲基纤维素等。
防腐剂包括:尼泊金类、苯甲酸、苯甲酸钠、山梨酸及其盐类、桉叶油等。
基质包括:虫蜡等。
临床观察:
为了进一步证明本发明的治疗糖尿病、心脑血管疾病的中药组合药物的有效性,将病人分为治疗组和对照组。治疗组157例,采用本发明的治疗糖尿病、心脑血管疾病的中药组合药物进行治疗,每天一组,每天分2-3次服用,10天为一疗程,服用2个疗程。对照组141例,服用二甲双胍片、阿卡波糖片、阿司匹林片、酒石酸美托洛尔片,服用疗程与治疗组相同。
疗效标准根据国家《中医病症诊断疗效标准》糖尿病相关疗效标准拟定:
有效:临床症状得到控制,血糖、血压下降≥49.5%,尿糖定性为阳性;
好转:血糖、血压下降≥35-40%,尿糖定性(++)以下;
无效:临床症状无明显改善,血糖、血压、尿糖变化不明显。
结果为:治疗组有效103例,好转52例,无效2例,总有效率98.73%。对照组有效65例,好转49例,无效27例,总有效率80.85%。
通过以上临床治疗结果对比,治疗组的疗效明显优于对照组,说明本发明的治疗糖尿病、心脑血管疾病的中药组合药物治疗糖尿病的疗效十分明显。
本发明的治疗糖尿病、心脑血管疾病的中药组合药物及其制备方法的有益效果:
(1)本发明的治疗糖尿病、心脑血管疾病的中药组合药物通过添加藏红花份、山药、生地、沙参、枣仁、漏芦、杜仲、黄连、鸡内金、五味子、当归、茯苓、黄芪、山萸肉、沉香、石斛、丹参和杞子等成分,可以有效提高患者的提免修复能力,安心、降压、护心脑、保修胰腺,既能温阳降糖,又能滋阴降压,且能减轻动脉硬化,避免血栓形成和动脉硬化性闭塞,对糖尿病和心血管疾病均有显著的治疗效果。
(2)本发明的治疗糖尿病、心脑血管疾病的中药组合药物制备方法的工艺简单,材料来源广泛,适于进行推广应用。
以上所述实施例仅表达了本发明的几种实施方式,其描述较为具体和详细,但并不能因此而理解为对发明专利范围的限制。应当指出的是,对于本领域的普通技术人员来说,在不脱离本发明构思的前提下,还可以做出若干变形和改进,这些都属于本发明的保护范围。
Claims (6)
1.一种治疗糖尿病、心脑血管疾病的中药组合药物,其特征在于,按质量份数计,包括:藏红花8-15份、山药10-20份、生地10-20份、沙参10-20份、枣仁15-25份、漏芦10-20份、杜仲10-22份、黄连5-15份、鸡内金10-20份、五味子15-25份、当归10-20份、茯苓10-20份、黄芪10-30份、山萸肉10-30份、沉香5-15份、石斛10-20份、丹参10-22份、杞子15-25份。
2.根据权利要求1所述的治疗糖尿病、心脑血管疾病的中药组合药物,其特征在于,按质量份数计,包括:藏红花10份、山药15份、生地15份、沙参15份、枣仁20份、漏芦15份、杜仲15份、黄连10份、鸡内金15份、五味子20份、当归15份、茯苓15份、黄芪20份、山萸肉20份、沉香10份、石斛15份、丹参15份、杞子20份。
3.一种治疗糖尿病、心脑血管疾病的中药组合药物制备方法,其特征在于,包括:分别称取藏红花、山药、生地、沙参、枣仁、漏芦、杜仲、黄连、鸡内金、五味子、当归、茯苓、黄芪、山萸肉、沉香、石斛、丹参、杞子,将所有药材混合,加入水,文火熬制1.5-2h,过滤,分出药渣和滤液,将滤液提纯,制成浓缩液。
4.根据权利要求3所述的治疗糖尿病、心脑血管疾病的中药组合药物制备方法,其特征在于,所述将所有药材混合,加入水,包括:将所有药材混合,加入水,其中,所有药材的总质量与水的质量比为1:10。
5.根据权利要求4所述的治疗糖尿病、心脑血管疾病的中药组合药物制备方法,其特征在于,将药渣再次回收利用,加入水,其中,药渣的质量与水的质量比为1:8,文火熬制1.5-2h,过滤得到滤液,将滤液提纯,制成浓缩液。
6.根据权利要求3-5任一项所述的治疗糖尿病、心脑血管疾病的中药组合药物制备方法,其特征在于,所述制备方法还包括:浓缩液加入常规辅料,按照常规工艺,制成临床上可接受的口服液、片剂、颗粒、胶囊、丸剂、散剂、膏剂。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010412871.XA CN111358895A (zh) | 2020-05-15 | 2020-05-15 | 治疗糖尿病、心脑血管疾病的中药组合药物及其制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010412871.XA CN111358895A (zh) | 2020-05-15 | 2020-05-15 | 治疗糖尿病、心脑血管疾病的中药组合药物及其制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN111358895A true CN111358895A (zh) | 2020-07-03 |
Family
ID=71200017
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010412871.XA Pending CN111358895A (zh) | 2020-05-15 | 2020-05-15 | 治疗糖尿病、心脑血管疾病的中药组合药物及其制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN111358895A (zh) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101524471A (zh) * | 2008-03-06 | 2009-09-09 | 北京中科仁和科技有限公司 | 一种用于治疗糖尿病的药物组合及其制备方法 |
-
2020
- 2020-05-15 CN CN202010412871.XA patent/CN111358895A/zh active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101524471A (zh) * | 2008-03-06 | 2009-09-09 | 北京中科仁和科技有限公司 | 一种用于治疗糖尿病的药物组合及其制备方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102258714B (zh) | 一种用于治疗高血压的中药胶囊 | |
| CN102423402A (zh) | 一种治疗盗汗的中药组合物 | |
| CN103301440B (zh) | 一种能够温阳补肾的中药 | |
| CN103536758A (zh) | 一种治疗阴虚盗汗的中药组合物 | |
| CN101549105A (zh) | 一种用于治疗偏头痛的中药组合物 | |
| CN105126043A (zh) | 一种治疗肝硬化的中药组合物及其用途 | |
| CN104435225A (zh) | 一种治疗高血压的中药及其胶囊的制备方法 | |
| CN104857277A (zh) | 一种溶解血栓的纯中药制剂及其制备方法 | |
| CN104645078A (zh) | 一种治疗偏头痛的中药组合物 | |
| CN103386055B (zh) | 一种前列安通胶囊及制备方法 | |
| CN111358895A (zh) | 治疗糖尿病、心脑血管疾病的中药组合药物及其制备方法 | |
| CN104547369A (zh) | 一种治疗眼睑痉挛的内服药物及其制备方法 | |
| CN102166311B (zh) | 一种治疗脾虚肝旺型甲状腺功能亢进症的中药制备方法 | |
| CN105963450A (zh) | 治疗眩晕昏厥的中药组合物 | |
| CN105617198A (zh) | 治疗风寒腰痛的药酒的制备方法 | |
| CN100546629C (zh) | 治疗肝阳上亢型更年期综合症的中药制剂及制备方法 | |
| CN105727089A (zh) | 含艾叶的药物组合物用于制备治疗肠易激综合症药物中的用途 | |
| CN104958677A (zh) | 一种治疗膜性肾病的中药制剂及其制备方法 | |
| CN104547425A (zh) | 一种治疗麻痹性斜视的汤剂药物及其制备方法 | |
| CN103330814A (zh) | 一种治疗肾阳虚的中药组合物 | |
| CN1236804C (zh) | 一种治痔胶囊的制法 | |
| CN110841007B (zh) | 一种治疗脑中风后遗症的中药组合物及其应用 | |
| CN106309685A (zh) | 一种用于治疗眩晕的中药组合物及其制备方法 | |
| CN106389821A (zh) | 一种治疗输血溶血反应的中药制剂及其制备方法 | |
| CN105362804A (zh) | 一种治疗轻度贫血的中药组合物及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200703 |